The Genes-Stemness-Secretome Interplay in Malignant Pleural Mesothelioma: Molecular Dynamics and Clinical Hints

被引:2
作者
Stella, Giulia M. [1 ,2 ]
Marchio, Caterina [3 ,4 ]
Bari, Elia [5 ]
Ferrarotti, Ilaria [1 ,2 ]
Bertuccio, Francesco R. [1 ,2 ]
Di Gennaro, Antonella [2 ]
Abbott, David Michael [6 ]
Putignano, Paola [1 ,2 ]
Campo, Ilaria [2 ]
Torre, Maria Luisa [5 ]
Corsico, Angelo G. [1 ,2 ]
机构
[1] Univ Pavia, Dept Internal Med & Med Therapeut, Med Sch, I-27100 Pavia, Italy
[2] IRCCS Policlin San Matteo, Cardiothorac & Vasc Dept, Unit Resp Dis, I-27100 Pavia, Italy
[3] Univ Turin, Dept Med Sci, I-10124 Turin, Italy
[4] FPO IRCCS Candiolo Canc Inst, Pathol Unit, Str Provinciale 142, I-10060 Candiolo, Italy
[5] Univ Piemonte Orientale, Dept Pharmaceut Sci, Largo Donegani 2-3, I-28100 Novara, Italy
[6] Univ Pavia, Dept Surg Pediat & Diagnost Sci, I-27100 Pavia, Italy
关键词
malignant pleural mesothelioma; genetics; microenvironment; targeted therapies; EXTRACELLULAR VESICLES; CELL NICHE; PROTEOMIC ANALYSIS; DNA-REPAIR; CANCER; HYPOXIA; EXPRESSION; EXOSOMES; CLASSIFICATION; IDENTIFICATION;
D O I
10.3390/ijms24043496
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
MPM has a uniquely poor somatic mutational landscape, mainly driven by environmental selective pressure. This feature has dramatically limited the development of effective treatment. However, genomic events are known to be associated with MPM progression, and specific genetic signatures emerge from the exceptional crosstalk between neoplastic cells and matrix components, among which one main area of focus is hypoxia. Here we discuss the novel therapeutic strategies focused on the exploitation of MPM genetic asset and its interconnection with the surrounding hypoxic microenvironment as well as transcript products and microvesicles representing both an insight into the pathogenesis and promising actionable targets.
引用
收藏
页数:21
相关论文
共 177 条
[1]   Malignant Pleural Mesothelioma: Genetic and Microenviromental Heterogeneity as an Unexpected Reading Frame and Therapeutic Challenge [J].
Abbott, David Michael ;
Bortolotto, Chandra ;
Benvenuti, Silvia ;
Lancia, Andrea ;
Filippi, Andrea Riccardo ;
Stella, Giulia Maria .
CANCERS, 2020, 12 (05)
[2]   Extracellular vesicles as biomarkers in malignant pleural mesothelioma: A review [J].
Ahmadzada, Tamkin ;
Kao, Steven ;
Reid, Glen ;
Clarke, Stephen ;
Grau, Georges E. ;
Hosseini-Beheshti, Elham .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2020, 150
[3]   Annotating non-coding regions of the genome [J].
Alexander, Roger P. ;
Fang, Gang ;
Rozowsky, Joel ;
Snyder, Michael ;
Gerstein, Mark B. .
NATURE REVIEWS GENETICS, 2010, 11 (08) :559-571
[4]   The PDL1-PD1 Axis Converts Human TH1 Cells into Regulatory T Cells [J].
Amarnath, Shoba ;
Mangus, Courtney W. ;
Wang, James C. M. ;
Wei, Fang ;
He, Alice ;
Kapoor, Veena ;
Foley, Jason E. ;
Massey, Paul R. ;
Felizardo, Tania C. ;
Riley, James L. ;
Levine, Bruce L. ;
June, Carl H. ;
Medin, Jeffrey A. ;
Fowler, Daniel H. .
SCIENCE TRANSLATIONAL MEDICINE, 2011, 3 (111)
[5]   Immune-Checkpoint Inhibitors for Malignant Pleural Mesothelioma: A French, Multicenter, Retrospective Real-World Study [J].
Assie, Jean-Baptiste ;
Crepin, Florian ;
Grolleau, Emmanuel ;
Canellas, Anthony ;
Geier, Margaux ;
Grebert-Manuardi, Aude ;
Akkache, Nabila ;
Renault, Aldo ;
Hauss, Pierre-Alexandre ;
Sabatini, Marielle ;
Bonnefoy, Valentine ;
Cortot, Alexis ;
Wislez, Marie ;
Gauvain, Clement ;
Chouaid, Christos ;
Scherpereel, Arnaud ;
Monnet, Isabelle .
CANCERS, 2022, 14 (06)
[6]   Identification of a Five-Gene Signature for Predicting Survival in Malignant Pleural Mesothelioma Patients [J].
Bai, Yiyang ;
Wang, Xiao ;
Hou, Jia ;
Geng, Luying ;
Liang, Xuan ;
Ruan, Zhiping ;
Guo, Hui ;
Nan, Kejun ;
Jiang, Lili .
FRONTIERS IN GENETICS, 2020, 11
[7]   Proteomic analysis of exosomes isolated from human malignant pleural effusions [J].
Bard, MP ;
Hegmans, JP ;
Hemmes, A ;
Luider, TM ;
Willemsen, R ;
Severijnen, LAA ;
van Meerbeeck, JP ;
Burgers, SA ;
Hoogsteden, HC ;
Lambrecht, BN .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2004, 31 (01) :114-121
[8]   Mesenchymal stem/stromal cell secretome for lung regeneration: The long way through "pharmaceuticalization" for the best formulation [J].
Bari, Elia ;
Ferrarotti, Ilaria ;
Torre, Maria Luisa ;
Corsico, Angelo Guido ;
Perteghella, Sara .
JOURNAL OF CONTROLLED RELEASE, 2019, 309 :11-24
[9]   Cancer stem cells revisited [J].
Batlle, Eduard ;
Clevers, Hans .
NATURE MEDICINE, 2017, 23 (10) :1124-1134
[10]   Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival [J].
Baumann, Francine ;
Flores, Erin ;
Napolitano, Andrea ;
Kanodia, Shreya ;
Taioli, Emanuela ;
Pass, Harvey ;
Yang, Haining ;
Carbone, Michele .
CARCINOGENESIS, 2015, 36 (01) :76-81